BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29359945)

  • 21. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
    Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
    Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide-pulsed splenic dendritic cells prime long-lasting CD8(+) T cell memory in the absence of cross-priming by host APC.
    Livingstone AM; Kuhn M
    Eur J Immunol; 2002 Jan; 32(1):281-90. PubMed ID: 11782019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maturation of dendritic cells in vitro and immunological enhancement of mice in vivo by pachyman- and/or OVA-encapsulated poly(d,l-lactic acid) nanospheres.
    Zheng S; Qin T; Lu Y; Huang Y; Luo L; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2018; 13():569-583. PubMed ID: 29416336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.
    Brooks N; Hsu J; Esparon S; Pouniotis D; Pietersz GA
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
    Brooks N; Esparon S; Pouniotis D; Pietersz GA
    Molecules; 2015 Aug; 20(8):14033-50. PubMed ID: 26247926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles.
    Shima F; Akagi T; Uto T; Akashi M
    Biomaterials; 2013 Dec; 34(37):9709-16. PubMed ID: 24016848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine.
    Tateshita N; Miura N; Tanaka H; Masuda T; Ohtsuki S; Tange K; Nakai Y; Yoshioka H; Akita H
    J Control Release; 2019 Sep; 310():36-46. PubMed ID: 31386869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
    Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
    J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T cells.
    Sakamoto N; Rosenberg AS
    J Immunol; 2011 Apr; 186(8):5004-11. PubMed ID: 21402897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
    Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
    Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.
    Sheng KC; Kalkanidis M; Pouniotis DS; Esparon S; Tang CK; Apostolopoulos V; Pietersz GA
    Eur J Immunol; 2008 Feb; 38(2):424-36. PubMed ID: 18200633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses.
    Mattheolabakis G; Lagoumintzis G; Panagi Z; Papadimitriou E; Partidos CD; Avgoustakis K
    Int J Pharm; 2010 Jan; 385(1-2):187-93. PubMed ID: 19874877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
    Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
    ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modular core-shell polymeric nanoparticles mimicking viral structures for vaccination.
    Lou B; De Beuckelaer A; Boonstra E; Li D; De Geest BG; De Koker S; Mastrobattista E; Hennink WE
    J Control Release; 2019 Jan; 293():48-62. PubMed ID: 30428307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.
    Zhao JH; Zhang QB; Liu B; Piao XH; Yan YL; Hu XG; Zhou K; Zhang YT; Feng NP
    Int J Nanomedicine; 2017; 12():4763-4772. PubMed ID: 28740383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses.
    Li P; Luo Z; Liu P; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
    J Control Release; 2013 Jun; 168(3):271-9. PubMed ID: 23562637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
    Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
    J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.